Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer.

CONCLUSIONS: This nationwide retrospective cohort study provides evidence supporting CHM as an effective adjunctive therapy to ameliorate the side effects of target therapy and prolong the five-year survival rate of patients with advanced NSCLC. PMID: 30219465 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30219465?dopt=Abstract

Source: Complementary Therapies in Medicine - September 18, 2018 Category: Complementary Medicine Authors: Wang CY, Huang HS, Su YC, Tu CY, Hsia TC, Huang ST Tags: Complement Ther Med Source Type: research